Viatris Q3 net loss more than doubles to $325.3 million year over year
VTRS•Viatris reported a third-quarter 2026 GAAP net loss of $325.3 million, while revenue fell to $3.75 billion and operating cash flow rose 21% to $899.4 million. The company raised its 2026 revenue guidance midpoint to $14.8 billion, excluding Pacira.
1. Quarterly results
Viatris’ third-quarter 2026 GAAP net loss more than doubled year over year to $325.3 million. Total revenues fell to $3.75 billion, while GAAP operating cash flow increased 21% to $899.4 million.
2. Supply and outlook
Supply constraints reduced quarterly revenue by approximately $100 million, with a similar impact expected in the fourth quarter. Viatris raised its 2026 total revenue guidance midpoint to $14.8 billion, excluding any contribution from Pacira.
3. Pacira acquisition
Viatris expects its planned $1.65 billion acquisition of Pacira BioSciences to close by the end of November 2026.
